Literature DB >> 17991649

Serum 25-hydroxyvitamin D in a West African population of tuberculosis patients and unmatched healthy controls.

Christian Wejse1, Rikke Olesen, Paulo Rabna, Pernille Kaestel, Per Gustafson, Peter Aaby, Paul L Andersen, Henning Glerup, Morten Sodemann.   

Abstract

BACKGROUND: Little is known regarding vitamin D deficiency (VDD) in African populations and in tuberculosis (TB) patients. VDD has been shown to be associated with TB.
OBJECTIVE: We aimed to compare the degree of vitamin D insufficiency (VDI) and VDD in TB patients and healthy adult controls in a West African population.
DESIGN: An unmatched case-control study was performed at a Demographic Surveillance Site in Guinea-Bissau. Serum 25-hydroxyvitamin D(3) [25(OH)D(3)] concentrations were measured in 362 TB patients and in 494 controls.
RESULTS: Hypovitaminosis D [25(OH)D(3) </= 75 nmol/L] was more common in TB patients, but VDD [25(OH)D(3) </= 50 nmol/L] was more common and more severe in controls. We observed hypovitaminosis D in 46% (167/362) of the TB patients and in 39% (193/494) of the controls; the relative risk (RR) of hypovitaminosis D was 1.18 (95% CI: 1.01, 1.38). VDD was observed in 8.5% (31/362) of the TB patients and in 13.2% (65/494) of the controls. The RR was 0.65 (95% CI: 0.43, 0.98), mainly because severe VDD [25(OH)D(3) </= 25 nmol/L] was observed in only 1 of 362 TB patients (0.2%) and in 24 of 494 controls (4.9%). After adjustment for background factors, hypovitaminosis D was not more frequent in TB patients than in healthy controls, but the mean serum 25(OH)D(3) concentration remained lower.
CONCLUSIONS: Hypovitaminosis D was highly prevalent in TB patients and in healthy controls living at 12 degrees N; severe VDD was rare in TB patients. The finding indicates that the serum 25(OH)D(3) concentration is associated with TB infection, but whether this role is a symptom or is causal was not established.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17991649     DOI: 10.1093/ajcn/86.5.1376

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  59 in total

Review 1.  Immunomodulation by vitamin D: implications for TB.

Authors:  Rene F Chun; John S Adams; Martin Hewison
Journal:  Expert Rev Clin Pharmacol       Date:  2011-09       Impact factor: 5.045

2.  Vitamin D and calcium levels in Ugandan adults with human immunodeficiency virus and tuberculosis.

Authors:  D Nansera; F M Graziano; D J Friedman; M K Bobbs; A N Jones; K E Hansen
Journal:  Int J Tuberc Lung Dis       Date:  2011-11       Impact factor: 2.373

3.  Relationship of vitamin D insufficiency to AIDS-associated Kaposi's sarcoma outcomes: retrospective analysis of a prospective clinical trial in Zimbabwe.

Authors:  Kristine M Erlandson; Ivy Gudza; Suzanne Fiorillo; Buxton Ndemera; Robert T Schooley; Lovemore Gwanzura; Margaret Borok; Thomas B Campbell
Journal:  Int J Infect Dis       Date:  2014-04-21       Impact factor: 3.623

4.  High-dose vitamin D3 in adults with pulmonary tuberculosis: a double-blind randomized controlled trial.

Authors:  Nestan Tukvadze; Ekaterina Sanikidze; Maia Kipiani; Gautam Hebbar; Kirk A Easley; Neeta Shenvi; Russell R Kempker; Jennifer K Frediani; Veriko Mirtskhulava; Jessica A Alvarez; Nino Lomtadze; Lamara Vashakidze; Li Hao; Carlos Del Rio; Vin Tangpricha; Henry M Blumberg; Thomas R Ziegler
Journal:  Am J Clin Nutr       Date:  2015-09-23       Impact factor: 7.045

Review 5.  The regulatory role of miRNAs on VDR in breast cancer.

Authors:  Tatyana Singh; Brian D Adams
Journal:  Transcription       Date:  2017-06-09

Review 6.  Vitamin D: effects on childhood health and disease.

Authors:  Steven A Abrams; Jorge A Coss-Bu; Dov Tiosano
Journal:  Nat Rev Endocrinol       Date:  2013-02-05       Impact factor: 43.330

Review 7.  Novel adjunctive therapies for the treatment of tuberculosis.

Authors:  A A Ordonez; M Maiga; S Gupta; E A Weinstein; W R Bishai; S K Jain
Journal:  Curr Mol Med       Date:  2014-03       Impact factor: 2.222

8.  Vitamin D status, vitamin D receptor and toll like receptor-2 polymorphisms in tuberculous meningitis: a case-control study.

Authors:  Imran Rizvi; Ravindra Kumar Garg; Amita Jain; Hardeep Singh Malhotra; Arvind Kumar Singh; Shantanu Prakash; Neeraj Kumar; Rajeev Garg; Rajesh Verma; Abbas Ali Mahdi; Praveen Kumar Sharma
Journal:  Infection       Date:  2016-05-20       Impact factor: 3.553

9.  Modifiable risk factors associated with tuberculosis disease in children in Pune, India.

Authors:  J Jubulis; A Kinikar; M Ithape; M Khandave; S Dixit; S Hotalkar; V Kulkarni; V Mave; N Gupte; A Kagal; S Jain; R Bharadwaj; A Gupta
Journal:  Int J Tuberc Lung Dis       Date:  2014-02       Impact factor: 2.373

10.  Is vitamin D deficiency involved in the immune reconstitution inflammatory syndrome?

Authors:  Anali Conesa-Botella; Chantal Mathieu; Robert Colebunders; Rodrigo Moreno-Reyes; Evelyne van Etten; Lut Lynen; Luc Kestens
Journal:  AIDS Res Ther       Date:  2009-04-21       Impact factor: 2.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.